Influence of repetitive transcranial magnetic stimulation on psychomotor symptoms in major depression.
Psychomotor symptoms related to an impairment of the nigrostriatal dopaminergic system are frequent in major depression (MD). Repetitive transcranial magnetic stimulation (rTMS) has been discussed as a new treatment option for MD. In neurobiological terms, an influence of high-frequency rTMS on dopaminergic neurotransmission has previously been shown by several studies in animals and humans. Therefore, an improvement of psychomotor symptoms by rTMS could be assumed. The aim of this pilot study was to investigate the effect of high-frequency rTMS on psychomotor retardation and agitation in depressive patients. We investigated the effect of left prefrontal 10 Hz rTMS on psychomotor retardation and agitation in 30 patients with MD. Patients were randomly assigned to real or sham rTMS in addition to a newly initiated standardized antidepressant medication. We found a trend in the reduction of agitation (t(28) = 1.76, p = 0.09, two-tailed), but not in the reduction of retardation. Furthermore, no general additional antidepressant effect of rTMS was observed. Although there was no statistical significant influence of high-frequency rTMS on psychomotor symptoms in depressive patients, the results showed a trend in the reduction of psychomotor agitation in MD. This effect should be systematically investigated as the primary end point in further studies with larger sample sizes.
Hoeppner
Jacqueline
J
Department of Psychiatry and Psychotherapy, Center of Nervous Diseases, University of Rostock, Gehlsheimer Str. 20, 18147, Rostock, Germany. jacqueline.hoeppner@med.uni-rostock.de
Padberg
Frank
F
Domes
Gregor
G
Zinke
Antonia
A
Herpertz
Sabine C
SC
Grossheinrich
Nicola
N
Herwig
Uwe
U
D000293:Adolescent; D000328:Adult; D000368:Aged; D003865:Major Depressive Disorder / Q000150:complications / Q000628:therapy; D005260:Female; D007839:Functional Laterality / Q000502:physiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D017397:Prefrontal Cortex / Q000502:physiology; D011596:Psychomotor Disorders / Q000209:etiology / Q000628:therapy*; D012720:Severity of Illness Index; D018709:Statistics, Nonparametric; D050781:Transcranial Magnetic Stimulation / Q000379:methods*; D055815:Young Adult
Arch Gen Psychiatry. 2005 Nov;62(11):1228-36
16275810
Brain. 2003 Dec;126(Pt 12):2609-15
12937078
Psychoneuroendocrinology. 2008 Jul;33(6):821-31
18468810
Am J Psychiatry. 2006 Sep;163(9):1594-602
16946186
Eur Arch Psychiatry Clin Neurosci. 2009 Feb;259(1):55-63
18806921
Br J Psychiatry. 2007 Nov;191:441-8
17978325
Eur Arch Psychiatry Clin Neurosci. 2009 Mar;259(2):92-7
18806917
Psychoneuroendocrinology. 2003 Apr;28(3):376-85
12573303
Am J Psychiatry. 2002 Aug;159(8):1427-9
12153840
Eur Arch Psychiatry Clin Neurosci. 2003 Apr;253(2):103-9
12799750
J Neurosci. 2001 Aug 1;21(15):RC157
11459878
J Psychiatr Res. 2006 Jun;40(4):307-14
16259998
Neurotox Res. 2004;6(4):317-25
15545015
Ann Neurol. 2002 May;51(5):599-603
12112106
Neuropharmacology. 2002 Jul;43(1):101-9
12213264
Mov Disord. 2007 Jun 15;22(8):1150-6
17469208
Acta Psychiatr Scand. 1999 Apr;99(4):252-6
10223426
J Pharmacol Sci. 2003 Dec;93(4):451-7
14737016
Brain. 2007 Jul;130(Pt 7):1799-807
17329323
J Neuropsychiatry Clin Neurosci. 1998 Winter;10(1):85-92
9547471
Psychol Med. 1987 Aug;17(3):609-19
3628622
Twin Res Hum Genet. 2006 Oct;9(5):632-6
17032542
Neuroreport. 2006 Nov 6;17(16):1703-7
17047457
Neuroreport. 2005 Oct 17;16(15):1715-8
16189484
J Affect Disord. 2000 Oct;60(1):1-11
10940442